Innoviva (INVA) Gross Profit (2011 - 2026)
Innoviva posted quarterly Gross Profit of $75.8 million for Q1 2026, up 3.43% year-on-year from $73.3 million in Q1 2025, and little changed on a QoQ basis from $75.5 million in Q3 2025.
Innoviva (INVA) has 9 years of Gross Profit data on file, last reported at $75.8 million in Q1 2026.
- For the quarter ending Q1 2026, Gross Profit rose 3.43% year-over-year to $75.8 million; the trailing twelve-month figure through Mar 2026 stood at $307.8 million (up 5.64% YoY), and the FY2025 full-year result was $307.7 million, up 3.87% from the prior year.
- Gross Profit for Q1 2026 stood at $75.8 million, roughly flat from $75.5 million in the prior quarter.
- Across five years, Gross Profit topped out at $85.0 million in Q2 2024 and bottomed at -$8.0 million in Q2 2023.
- The 5-year median for Gross Profit is $67.3 million (2023), against an average of $45.3 million.
- The widest annual swing landed in 2023, when Gross Profit tumbled 524.8%; it then soared 7573.63% in 2024.
- A 5-year view of Gross Profit shows it stood at $1.3 million in 2022, then soared by 5073.77% to $67.3 million in 2023, then rose by 8.55% to $73.0 million in 2024, then rose by 3.47% to $75.5 million in 2025, then grew by 0.39% to $75.8 million in 2026.
- The last three Gross Profit figures came in at $75.8 million (Q1 2026), $75.5 million (Q3 2025), and $83.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.83 Mn |
| Mar 31, 2026 | 75.83 Mn |
| Sep 30, 2025 | 75.54 Mn |
| Sep 30, 2025 | 75.54 Mn |
| Jun 30, 2025 | 83.15 Mn |
| Jun 30, 2025 | 83.15 Mn |
| Mar 31, 2025 | 73.32 Mn |
| Mar 31, 2025 | 73.32 Mn |
| Sep 30, 2024 | 73.01 Mn |
| Sep 30, 2024 | 73.01 Mn |
| Jun 30, 2024 | 84.99 Mn |
| Jun 30, 2024 | 84.99 Mn |
| Mar 31, 2024 | 60.09 Mn |
| Mar 31, 2024 | 60.09 Mn |
| Sep 30, 2023 | 67.26 Mn |
| Sep 30, 2023 | 67.26 Mn |
| Jun 30, 2023 | -8.00 Mn |
| Jun 30, 2023 | -8.00 Mn |
| Mar 31, 2023 | -804,000.00 |
| Mar 31, 2023 | -804,000.00 |
| Sep 30, 2022 | 1.30 Mn |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | 1.24 Mn |
| Mar 31, 2022 | 1.24 Mn |
| Sep 30, 2021 | 97.86 Mn |
| Sep 30, 2021 | 97.86 Mn |
| Mar 31, 2014 | 592,000.00 |
| Mar 31, 2014 | 592,000.00 |
| Mar 31, 2013 | 1.32 Mn |
| Mar 31, 2013 | 1.32 Mn |
| Dec 31, 2011 | 5.36 Mn |
| Dec 31, 2011 | 5.36 Mn |
| Sep 30, 2011 | 6.43 Mn |
| Sep 30, 2011 | 6.43 Mn |
| Jun 30, 2011 | 5.21 Mn |
| Jun 30, 2011 | 5.21 Mn |